We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Impact of Medical Emergency Team and EMS in Tampere University Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01214460
Recruitment Status : Active, not recruiting
First Posted : October 5, 2010
Last Update Posted : May 2, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Patients in general wards have abnormal physical values preceding in-hospital cardiac arrest or a transfer to intensive care unit (ICU). The purpose of Medical Emergency Team (MET) or EMS is to interfere early enough in deteriorating patient status to prevent adverse outcomes like cardiac arrest or transfer to intensive care unit. The aims of this study are to record and analyze the effects of EMS and department of emergency and both afferent and efferent limbs of MET activity in Finnish tertiary Hospital.

Condition or disease
Death, Sudden,Cardiac

Study Design

Study Type : Observational
Actual Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact of Medical Emergency Team and EMS on ICU Readmissions and Sudden Cardiac Arrests in Tampere University Hospital
Study Start Date : January 2010
Primary Completion Date : July 2016
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
All MET calls
We make an Utstein type analyze to all MET calls
All EMS calls
We make an Utstein type analyze to all EMS calls during June 2015
All patient in the emergency department
We make an Utstein type analyze to all Emergency visits during June 2015


Outcome Measures

Primary Outcome Measures :
  1. In-hospital mortality [ Time Frame: patients are followed until death ]

Secondary Outcome Measures :
  1. The rates of ICU readmissions [ Time Frame: one month to six year ]
  2. The rates of DNAR orders [ Time Frame: one month to six year ]
  3. The number of patients EMS or medical emergency team is called to treat [ Time Frame: one month to six years ]
    We are going to analyze the number of MET calls and their impact on sudden cardiac arrests in TAUH. The time frame is 1st Jan 2010 -31st Dec 2015. It is known fact that well working MET team inside the hospital should decrease the sudden cardiac arrests. We also analyze the EMS calls and the ED visits in June 2015 to see if patient detoriation is related to sudden in-hospital death.

  4. Patient mortality after 6 mo of discharge [ Time Frame: one month to six year ]
    The patients are followed 6 mo after hospital discharge which has happened in year 2010


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All adult EMS or in-hospital patients with deteriorating vital signs or patients in risk in Tampere University Hospital
Criteria

Inclusion Criteria:

  • 18 yrs or older

Exclusion Criteria:

  • under 18 yrs
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01214460


Locations
Finland
Tampere University Hospital
Tampere, Pirkanmaa, Finland, 33521
Sponsors and Collaborators
Tampere University Hospital
Investigators
Principal Investigator: Jari Kalliomäki, MD Tampere University Hospital
Principal Investigator: Sanna Hoppu, MD, PhD Tampere University Hospital
Principal Investigator: Joonas Tirkkonen, MD Tampere University Hospital
Principal Investigator: Timo Kontula, MD Tampere University Hospital
Principal Investigator: Eetu Loisa Tampere University Hospital
More Information

Responsible Party: Tampere University Hospital
ClinicalTrials.gov Identifier: NCT01214460     History of Changes
Other Study ID Numbers: R10111
First Posted: October 5, 2010    Key Record Dates
Last Update Posted: May 2, 2017
Last Verified: April 2017

Keywords provided by Tampere University Hospital:
MET

Additional relevant MeSH terms:
Emergencies
Death, Sudden
Death, Sudden, Cardiac
Disease Attributes
Pathologic Processes
Death
Heart Arrest
Heart Diseases
Cardiovascular Diseases